Noveris Health Sciences is trading at CA$0.20, up +5.41%, amid volatile recovery trading after its 40.98% decline on August 18.

  • No new company-specific announcement was identified on August 20, 2026.
  • Noveris’s August 18 USPTO patent allowance and CA$146,000 API work order remain the latest major company news.
  • Broader market sentiment is cautious as Treasury yields resume climbing, limiting conviction.